Evercore ISI Group Maintains Outperform on 89bio, Lowers Price Target to $33
Portfolio Pulse from Benzinga Newsdesk
Evercore ISI Group analyst Liisa Bayko maintains an Outperform rating on 89bio (NASDAQ:ETNB) but lowers the price target from $37 to $33.
May 15, 2024 | 1:20 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Evercore ISI Group analyst Liisa Bayko maintains an Outperform rating on 89bio but lowers the price target from $37 to $33.
The Outperform rating suggests a positive outlook, but the lowered price target indicates some tempered expectations. This mixed signal is likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100